Market Research Logo

Europe Depression Market and Competitive Landscape – 2017

Europe Depression Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Europe Depression Market and Competitive Landscape – 2017, provides comprehensive insights into Depression pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Depression market size and drug sales. This research also provides insights into Depression epidemiology and late stage pipeline.
The report is classified into nine sections – Depression overview with definitions, symptoms, etiology, diagnosis, treatment options; Depression pipeline insights covering late stage clinical trials pipeline; Depression prevalence trends by countries; Depression market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries – Germany, France, Italy, Spain, UK, Europe.

Research Scope:

  • Depression pipeline: Find out the drugs in clinical trials for Depression by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Depression epidemiology: Find out the prevalence of Depression by countries – Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Depression products: Identify key products marketed and prescribed for Depression by brand name, by molecule, by company, by branded / generic, by countries – Europe, Germany, France, Italy, Spain, UK, Japan
  • Depression market size: Find out the market size for Depression drugs by countries – Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Depression drug sales: Find out the sales of Depression drugs by countries – Europe, Germany, France, Italy, Spain, UK
  • Depression drugs sales forecast: Sales forecast for Depression drugs to 2021 by countries – Europe, Germany, France, Italy, Spain, UK, Japan
  • Depression market share analysis: Find out the market shares of Depression drugs and outlook by countries – Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Depression drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Depression market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Depression market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


1. Depression: Disease Overview
1.1. Depression Symptoms
1.2. Depression Etiology
1.3. Depression Diagnosis
1.4. Depression Treatment Options
2. Depression Pipeline Insights
2.1. Depression Phase 3 Clinical Trials
2.2. Depression Phase 2 Clinical Trials
2.3. Depression Phase 1 Clinical Trials
3. Depression Epidemiology Analysis
4. Germany Depression Market Insights
4.1. Marketed Products for Depression in Germany
4.2. Germany Depression Market Size & Forecast
4.3. Germany Depression Product Sales Forecast
4.4. Germany Depression Market Share Analysis
5. France Depression Market Insights
5.1. Marketed Products for Depression in France
5.2. France Depression Market Size & Forecast
5.3. France Depression Product Sales Forecast
5.4. France Depression Market Share Analysis
6. Italy Depression Market Insights
6.1. Marketed Products for Depression in Italy
6.2. Italy Depression Market Size & Forecast
6.3. Italy Depression Product Sales Forecast
6.4. Italy Depression Market Share Analysis
7. Spain Depression Market Insights
7.1. Marketed Products for Depression in Spain
7.2. Spain Depression Market Size & Forecast
7.3. Spain Depression Product Sales Forecast
7.4. Spain Depression Market Share Analysis
8. UK Depression Market Insights
8.1. Marketed Products for Depression in UK
8.2. UK Depression Market Size & Forecast
8.3. UK Depression Product Sales Forecast
8.4. UK Depression Market Share Analysis
9. Europe Depression Market Insights
9.1. Europe Depression Market Size & Forecast
9.2. Europe Depression Product Sales Forecast
9.3. Europe Depression Market Share Analysis
10. Research Methodology
LIST OF TABLES
Table 1: Depression Phase 3 Clinical Trials, Global, 2017
Table 2: Depression Phase 2 Clinical Trials, Global, 2017
Table 3: Depression Phase 1 Clinical Trials, Global, 2017
Table 4: Depression Prevalence by EU5 Countries, 2012 - 2021
Table 5: Marketed Products for Depression in Germany, 2017
Table 6: Germany Depression Market Size & Forecast ($mn), 2012 - 2021
Table 7: Germany Depression Product Sales ($mn), 2012 - 2021
Table 8: Germany Depression Market Trends, 2012 - 2021
Table 9: Marketed Products for Depression in France, 2017
Table 10: France Depression Market Size & Forecast ($mn), 2012 - 2021
Table 11: France Depression Product Sales ($mn), 2012 - 2021
Table 12: France Depression Market Trends, 2012 - 2021
Table 13: Marketed Products for Depression in Italy, 2017
Table 14: Italy Depression Market Size & Forecast ($mn), 2012 - 2021
Table 15: Italy Depression Product Sales ($mn), 2012 - 2021
Table 16: Italy Depression Market Trends, 2012 - 2021
Table 17: Marketed Products for Depression in Spain, 2017
Table 18: Spain Depression Market Size & Forecast ($mn), 2012 - 2021
Table 19: Spain Depression Product Sales ($mn), 2012 - 2021
Table 20: Spain Depression Market Trends, 2012 - 2021
Table 21: Marketed Products for Depression in UK, 2017
Table 22: UK Depression Market Size & Forecast ($mn), 2012 - 2021
Table 23: UK Depression Product Sales ($mn), 2012 - 2021
Table 24: UK Depression Market Trends, 2012 - 2021
Table 25: Europe Depression Market Size & Forecast ($mn), 2012 - 2021
Table 26: Europe Depression Product Sales ($mn), 2012 - 2021
LIST OF FIGURES
Figure 1: Depression Pipeline by Phase (%), Global, 2017
Figure 2: Depression Prevalence by EU5 Countries, 2012 - 2021
Figure 3: Germany Depression Market Size ($mn), 2012 - 2021
Figure 4: Germany Depression Product Sales ($mn), 2012 - 2021
Figure 5: Germany Depression Market Share by Products (%), 2016
Figure 6: Germany Depression Market - Future Market Share (%), 2021
Figure 7: France Depression Market Size ($mn), 2012 - 2021
Figure 8: France Depression Product Sales ($mn), 2012 - 2021
Figure 9: France Depression Market Share by Products (%), 2016
Figure 10: France Depression Market - Future Market Share (%), 2021
Figure 11: Italy Depression Market Size ($mn), 2012 - 2021
Figure 12: Italy Depression Product Sales ($mn), 2012 - 2021
Figure 13: Italy Depression Market Share by Products (%), 2016
Figure 14: Italy Depression Market - Future Market Share (%), 2021
Figure 15: Spain Depression Market Size ($mn), 2012 - 2021
Figure 16: Spain Depression Product Sales ($mn), 2012 - 2021
Figure 17: Spain Depression Market Share by Products (%), 2016
Figure 18: Spain Depression Market - Future Market Share (%), 2021
Figure 19: UK Depression Market Size ($mn), 2012 - 2021
Figure 20: UK Depression Product Sales ($mn), 2012 - 2021
Figure 21: UK Depression Market Share by Products (%), 2016
Figure 22: UK Depression Market - Future Market Share (%), 2021
Figure 23: Europe Depression Market Size ($mn), 2012 - 2021
Figure 24: Europe Depression Product Sales ($mn), 2012 - 2021
Figure 25: Europe Depression Market Share by Products (%), 2016
Figure 26: Europe Depression Market - Future Market Share (%), 2021

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report